Seminars & Webinars
Messenger RNA is poised to become a major contributor in the fields of gene therapy and vaccines. Making this a practical reality requires purification technology that accommodates its unique features and challenges. Some of those challenges are inherent to mRNA. Others are byproducts of RNA synthesis.
This presentation addresses both and introduces a coordinated purification toolbox to advance the evolution of mRNA therapy.
Presenter: Ingo Nagler
Date: May 14, 2020
Asia’s SARS-CoV-2 Vaccine Development Challenges (Corona360 In-Conversation webcast series)